Symptom persistence and biomarkers in post-COVID-19/chronic fatigue syndrome – results from a prospective observational cohort
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (Rapid Reviews Infectious Diseases)
Abstract
Introduction
Post-COVID-19 syndrome (PCS) is characterized by a wide range of symptoms, predominantly fatigue and exertional intolerance. While disease courses during the first year post infection have been repeatedly described, little is known about long-term health consequences.
Methods
We assessed symptom severity and various biomarkers at three time points post infection (3-8 months (mo), 9-16mo, 17-20mo) in 106 PCS patients with moderate to severe fatigue and exertional intolerance. A subset of patients fulfilled diagnostic criteria of myalgic encephalomyelitis/chronic fatigue syndrome (PCS-ME/CFS) based on the Canadian Consensus Criteria.
Results
While PCS-ME/CFS patients showed persisting symptom severity and disability up to 20mo post infection, PCS patients reported an overall health improvement. Inflammatory biomarkers equally decreased in both groups. Lower hand grip force at onset correlated with symptom persistence especially in PCS-ME/CFS.
Discussion
Debilitating PCS may persist beyond 20mo post infection, particularly in patients fulfilling diagnostic criteria for ME/CFS.
Article activity feed
-
Ruud Raijmakers
Review 2: "Symptom Persistence and Biomarkers in Post-COVID-19/Chronic Fatigue Syndrome – Results From a Prospective Observational Cohort"
In its current state as a preprint, descriptions of several methods and supplemental data are also not available, making it more difficult to fully assess certain results.
-
Andrew Lloyd
Review 1: "Symptom Persistence and Biomarkers in Post-COVID-19/Chronic Fatigue Syndrome – Results From a Prospective Observational Cohort"
In its current state as a preprint, descriptions of several methods and supplemental data are also not available, making it more difficult to fully assess certain results.
-
Strength of evidence
Reviewers: A Lloyd (UNSW Sydney | 📒📒📒 ◻️◻️
R Raijmakers (Amsterdam UMC) | 📗📗📗📗◻️ -